Another factor that may inhibit the realization of stable treatment may be the narrowing of treatment options for PD in patients with depression, as the concomitant use of monoamine oxidase B inhibitors, one of the major anti-PD drug classes, with antidepressants is contraindicated in such patients. This evidence concerns the gene MAOB and depressive symptom measurement.